Skip to content

Cassava Intervention Project

Toxicodietary and Genetic Determinants of Susceptibility to Neurodegeneration

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03157336
Enrollment
1200
Registered
2017-05-17
Start date
2017-07-30
Completion date
2022-06-01
Last updated
2022-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurotoxicity Syndrome, Cassava, Neurotoxicity Syndrome, Cyanate, Neurotoxicity Syndrome, Cyanide, Neurotoxicity Syndrome, Thiocyanate

Keywords

Cassava, Konzo, Cyanide, Cyanate, Thiocyanate, Carbamoylation, Isoprostanes, Oxidative Damage

Brief summary

Investigators will implement a novel cassava processing method (wetting method, WTM) that safely removes cyanogenic compounds from cassava flour prior to human consumption in a stratified village-cluster randomized non-inferiority trial so as to compare the effectiveness of a peer-led intervention (women training other women in the WTM) with that by community-health worker specialists.

Detailed description

The proposed project seeks methods to prevent and elucidate biomarkers of neurocognition and motor deficits associated with chronic dietary reliance on cyanogenic cassava, a staple food crop for more than 600 millions of people living in the tropics. Aim 1 will implement a novel cassava processing method (wetting method, WTM) that safely removes cyanogenic compounds from cassava flour prior to human consumption in a stratified village-cluster randomized non-inferiority trial so as to compare the effectiveness of a peer-led intervention (women training other women in the WTM) with that by community-health worker specialists (2 intervention training arms). Aim 2 will determine whether post-intervention reductions in cassava cyanogenic content and child U-SCN are associated with changes in biomarkers of cassava neurotoxicity particularly 8,12-iso-iPF2α-VI isoprostane (oxidant marker), carbamoylated albumin fragments KVPQVSTPTLVEVSR (residues 438-452) and LDELRDEGKASSAK (residues 206-219), or homocitrulline (carbamoylating markers), and scores at the KABC-II cognition and BOT-2 motor testing.

Interventions

OTHERNon Inferiority WTM Interventional Trial

The intervention will implement the WTM cassava processing technique in participating households. Twenty women (in leading roles) will be our principal candidates to serve as peer trainers. Together with a 20 community health worker specialists, these women will be trained in the WTM technique by the Kinshasa team of community health workers who are experts in the WTM method. Those who master the technique will then be certified as trainers to train and support other small groups of other mothers throughout a two-year period in the implementation of the WTM for the safer processing of food for their families. Both the community health worker specialists and trained women (prospective trainers) would have to be able to bring the cassava cyanogenic content to the lowest achievable level, which must be \< 10 ppm as per the recommendations of the World Health Organization.

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
Oregon Health and Science University
CollaboratorOTHER
Michigan State University
CollaboratorOTHER
University of Kinshasa
CollaboratorOTHER
National Institute of Environmental Health Sciences (NIEHS)
CollaboratorNIH
Ministry of Public Health, Democratic Republic of the Congo
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

We will implement a novel cassava processing method (wetting method, WTM) that safely removes cyanogenic compounds from cassava flour prior to human consumption in a stratified village-cluster randomized non-inferiority trial so as to compare the effectiveness of a peer-led intervention (Arm 1 = women training other women in the WTM) with that by community-health worker specialists (Arm 2= specialist led intervention arm)

Eligibility

Sex/Gender
ALL
Age
5 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Households with a konzo child and non-konzo sibling between 5 and 12 years * Presence of a biological mother primarily responsible for the household food preparation and caring for the children * Mother consenting to participate in this study

Exclusion criteria

* History of seizures * History of cerebral malaria * History of retroviral (HIV-HTLV) infections

Design outcomes

Primary

MeasureTime frameDescription
Change in internal cyanogenic exposureFrom baseline to 6-month time pointsUrinary concentrations of thiocyanate (U-SCN)
Change in carbamoylationFrom baseline to 6-month time pointsserum albumin peptidic carbamoylation
Change in carbamoylation surrogateFrom baseline to 6-month time pointsserum homocitrulline
Change in food cyanogenic exposureFrom baseline to 6-month time pointsCassava cyanogenic content
Change in oxidation damageFrom baseline to 6-month time pointsSerum isoprostanes

Secondary

MeasureTime frameDescription
Change in motor proficiencyFrom baseline to 6-month time pointsMotor proficiency Bruininks/Oseretsky Testing (BOT-2) score
Change in cognition performanceFrom baseline to 6-month time pointsKaufman Assessment Battery for Children (KABC-II) for cognition testing score

Countries

Democratic Republic of the Congo

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026